{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:05:19Z","timestamp":1792649119718,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jconrel.2020.06.027","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T02:47:11Z","timestamp":1593571631000},"page":"370-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"special_numbering":"C","title":["Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection"],"prefix":"10.1016","volume":"325","author":[{"given":"Gustavo","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Anderluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Tandrup","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Gallorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Brazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ferlenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell N.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek T.","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C.","family":"Baudner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Perrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.06.027_b0005","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2020.06.027_b0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.06.027_b0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a transformative technology for vaccine development to control infectious diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2020.06.027_b0020","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jconrel.2020.06.027_b0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2020.06.027_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/1479-0556-4-4","article-title":"Characterization of the ribonuclease activity on the skin surface","volume":"4","author":"Probst","year":"2006","journal-title":"Genetic vaccines and therapy"},{"key":"10.1016\/j.jconrel.2020.06.027_b0035","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2020.06.027_b0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.nano.2015.11.001","article-title":"Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines","volume":"12","author":"Demoulins","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.06.027_b0045","series-title":"Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA","author":"Goswami","year":"2019"},{"key":"10.1016\/j.jconrel.2020.06.027_b0050","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2020.06.027_b0055","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2020.06.027_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2013.54","article-title":"Rapidly produced SAM \u00ae vaccine against H7N9 influenza is immunogenic in mice","volume":"2","author":"Hekele","year":"2013","journal-title":"Emerging Microbes Infect."},{"key":"10.1016\/j.jconrel.2020.06.027_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2020.06.027_b0070","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2020.06.027_b0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/mp100208f","volume":"8","author":"Henriksen-Lacey","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.06.027_b0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/156720110791011774","article-title":"Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies","volume":"7","author":"McNeil","year":"2010","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.06.027_b0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye","volume":"303","author":"Patel","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.06.027_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000515","article-title":"Novel vaccines to human rabies","volume":"3","author":"Ertl","year":"2009","journal-title":"PLoS Negl.Trop. Dis."},{"key":"10.1016\/j.jconrel.2020.06.027_b0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2019.08.013","article-title":"A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations","volume":"143","author":"Lou","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.06.027_b0100","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2020.06.027_b0105","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.vaccine.2013.12.043","article-title":"Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses","volume":"32","author":"Gallorini","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2020.06.027_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2020.04.001","article-title":"Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes","author":"Chatzikleanthous","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.06.027_b0115","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2020.06.027_b0120","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/viro.1995.0049","article-title":"Immune effector mechanisms required for protection to rabies virus","volume":"214","author":"Xiang","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2020.06.027_b0125","first-page":"255","article-title":"Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin","volume":"40","author":"Wiktor","year":"1978","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jconrel.2020.06.027_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004746","article-title":"An mRNA vaccine encoding rabies virus glycoprotein induces protection against lethal infection in mice and correlates of protection in adult and newborn pigs","volume":"10","author":"Schnee","year":"2016","journal-title":"PLoS Negl.Trop. Dis."},{"key":"10.1016\/j.jconrel.2020.06.027_b0135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2009.10.022","article-title":"Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen","volume":"142","author":"Henriksen-Lacey","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.06.027_b0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2012.07.012","article-title":"Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response","volume":"164","author":"Kaur","year":"2012","journal-title":"J. Controlled Release : Off. J. Controlled Release Soc."},{"key":"10.1016\/j.jconrel.2020.06.027_b0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0005-2736(00)00126-7","article-title":"Biophysical and lipofection studies of DOTAP analogs","volume":"1464","author":"Regelin","year":"2000","journal-title":"Biochim. et Biophysica Acta (BBA) \u2013 Biomembranes"},{"key":"10.1016\/j.jconrel.2020.06.027_b0150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2010.01.035","article-title":"DC-Chol\/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery","volume":"390","author":"Zhang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.06.027_b0155","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1021\/bm1008124","article-title":"Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol\/DOPE-DNA lipoplexes","volume":"11","author":"Mu\u00f1oz-\u00dabeda","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.06.027_b0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2007.04.035","article-title":"Cationic liposome (DC-Chol\/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression","volume":"342","author":"Maitani","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.06.027_b0165","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/(SICI)1520-6017(200005)89:5<652::AID-JPS11>3.0.CO;2-H","article-title":"Use of Poly(ethylene glycol)\u2013Lipid Conjugates to Regulate the Surface Attributes and Transfection Activity of Lipid\u2013DNA Particles","volume":"89","author":"Harvie","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.06.027_b0170","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1023\/A:1024441702398","article-title":"Physicochemical properties of liposomes affecting apoptosis induced by cationic liposomes in macrophages","volume":"20","author":"Takano","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.06.027_b0175","doi-asserted-by":"crossref","unstructured":"A. Akinc, W. Querbes, S. De, J. Qin, M. Frank-Kamenetsky, K.N. Jayaprakash, M. Jayaraman, K.G. Rajeev, W.L. Cantley, J.R. Dorkin, J.S. Butler, L. Qin, T. Racie, A. Sprague, E. Fava, A. Zeigerer, M.J. Hope, M. Zerial, D.W.Y. Sah, K. Fitzgerald, M.A. Tracy, M. Manoharan, V. Koteliansky, A.d. Fougerolles, M.A. Maier, Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms, Molecular therapy : the journal of the American Society of Gene Therapy, 18 (2010) 1357\u20131364.","DOI":"10.1038\/mt.2010.85"},{"key":"10.1016\/j.jconrel.2020.06.027_b0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","article-title":"Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines","volume":"2","author":"Lutz","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2020.06.027_b0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.06.027_b0190","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","article-title":"Effect of vaccine administration modality on immunogenicity and efficacy","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2020.06.027_b0195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2018.00310","article-title":"Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection","volume":"9","author":"Tian","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2020.06.027_b0200","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ymthe.2019.08.007","article-title":"Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles","volume":"27","author":"Melo","year":"2019","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.jconrel.2020.06.027_b0205","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1021\/acsnano.9b01774","article-title":"The skin you are in: design-of-experiments optimization of lipid nanoparticle self-amplifying RNA formulations in human skin explants","volume":"13","author":"Blakney","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.06.027_b0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2012.202","article-title":"Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines","volume":"21","author":"Pollard","year":"2013","journal-title":"Molecular Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.jconrel.2020.06.027_b0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2017.09.041","article-title":"Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA","volume":"266","author":"Verbeke","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.06.027_b0220","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/14760584.2017.1355245","article-title":"Mechanism of action of mRNA-based vaccines","volume":"16","author":"Iavarone","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2020.06.027_b0225","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.1601877","article-title":"Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design","volume":"198","author":"Pepini","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2020.06.027_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-019-0095-2","article-title":"Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA","author":"Blakney","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2020.06.027_b0235","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2020.06.027_b0240","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.vaccine.2011.04.081","article-title":"Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines","volume":"29","author":"Carstens","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2020.06.027_b0245","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2011.10.012","article-title":"Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1\/Th2 immune responses","volume":"158","author":"Kaur","year":"2012","journal-title":"J. Controlled Release : Off. J. Controlled Release Soc."},{"key":"10.1016\/j.jconrel.2020.06.027_b0250","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/imm.12505","article-title":"CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes","volume":"146","author":"Lazzaro","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2020.06.027_b0255","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.9b00730","article-title":"Scale-independent microfluidic production of cationic liposomal adjuvants and development of enhanced lymphatic targeting strategies","author":"Roces","year":"2019","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592030362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592030362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:55:32Z","timestamp":1759161332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592030362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"alternative-id":["S016836592030362X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.06.027","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}